BHAV Acquisition Corp Announces Pricing of \$100 Million Initial Public Offering

Key Highlights for Investors

• IPO Size: BHAV Acquisition Corp (“BHAV”) has priced its initial public offering (IPO) at \$100 million.
• Unit Structure: The offering comprises 10,000,000 units at \$10.00 per unit. Each unit contains one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of a Class A ordinary share upon the consummation of BHAV’s initial business combination.
• Trust Account: All proceeds (\$10.00 per unit) will be deposited into a trust account managed by Continental Stock Transfer & Trust Company.
• Trading Information: Units will begin trading on the Nasdaq Global Market under the ticker symbol “BHAVU” on March 19, 2026. Once trading of the unit’s components begins separately, the Class A ordinary shares and rights will trade under “BHAV” and “BHAVR”, respectively.
• Management Team: The company is led by Chief Executive Officer and Director Giri Devanur, and Chief Financial Officer and Director Chaitanya Kumar Setti.
• Book-Running Manager: Maxim Group LLC is the sole book-running manager for the offering.
• Over-Allotment Option: The company has granted the underwriter a 45-day option to purchase up to 1,500,000 additional units at the IPO price (less underwriting discount) to cover over-allotments if any.
• Offering Closing Date: The offering is expected to close on March 20, 2026, subject to customary closing conditions.
• Regulatory Status: The registration statement (Form S-1, File No. 333-293399) for this IPO was declared effective by the SEC in March 2026. The offering is made only by means of a prospectus.
• Company Purpose: BHAV is a blank check company (SPAC), formed to effectuate a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Important Information for Shareholders

• Potential Share Price Sensitivity: The IPO announcement and the specific terms of the units (including the rights to additional shares upon business combination) are likely to be price sensitive, particularly once the units begin trading and as separate trading commences for the shares and rights.
• Over-Allotment Option: The underwriter’s option to purchase up to 1,500,000 additional units could impact share supply and demand dynamics post-offering.
• Business Combination Risk: Investors should note that the value of the units, shares, and rights will be significantly affected by the company’s ability to successfully consummate a business combination. There is no assurance that the offering will be completed as described, or at all, nor that the net proceeds will be used as anticipated.
• Forward-Looking Statements: The press release contains forward-looking statements relating to the IPO and the search for an initial business combination. These statements are subject to numerous conditions, many of which are beyond the company’s control, including those detailed in the prospectus and risk factors filed with the SEC.

Contact Information

BHAV Acquisition Corp
Giri Devanur, Chief Executive Officer
E-mail: [email protected]

Maxim Group LLC
300 Park Avenue, 16th Floor, New York, NY 10022
Attention: Syndicate Department
Tel: (212) 895-3745
Email: [email protected]

Investor Takeaway

The successful pricing and upcoming closing of BHAV Acquisition Corp’s \$100 million IPO represent a significant milestone for the company. As a SPAC, BHAV offers investors exposure to potential future mergers or acquisitions, with additional upside from the unit structure granting rights to more shares. However, investors should be aware of the risks inherent in SPACs, including business combination uncertainty and possible dilution from over-allotment options. The trading debut and subsequent separation of unit components could drive share price volatility. Forward-looking statements and risk factors should be closely reviewed in the company’s SEC filings.

Disclaimer

This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. The information herein is based on press releases and regulatory filings and may contain forward-looking statements subject to numerous risks and uncertainties. Investors should review official prospectus documents and consult financial advisors before making any investment decisions. The company undertakes no obligation to update statements herein for revisions or changes after the date of release, except as required by law.